HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dollar Shave Club Founder Steps Down As CEO; Beautycounter Under New Direction; Cosmetics Leadership News

Executive Summary

Jason Goldberger takes the helm of Unilever’s Dollar Shave Club, bringing a wealth of digital and retail experience from stints at Target, Amazon and, most recently, Sur La Table. More personal-care industry executive moves.

You may also be interested in...



Dollar Shave Club Focused On Growth Post-Viral Video Sensation

DSC changed the conversation around men's razors with a 2012 viral video smash in which CEO Michael Dubin championed the "f'ing great" quality, but above all the affordability, of the company's blades. The firm's humorous marketing, chock full of irreverent wit, snark and slapstick, has helped win more than 2 million subscribers to date, but DSC's success also signals a changing marketplace in which value increasingly is prioritized over tech enhancements.

Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups

Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150908

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel